2000: September: Dementia-Alzheimer’s Research Papers

2000: September: Dementia-Alzheimer’s Research Papers

           

Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci. 2000 Sep 15;20(18):6920-6.

Sawamura N, Morishima-Kawashima M, Waki H, Kobayashi K, Kuramochi T, Frosch MP, Ding K, Ito M, Kim TW, Tanzi RE, Oyama F, Tabira T, Ando S, Ihara Y. Mutant presenilin 2 transgenic mice. A large increase in the levels of Abeta 42 is presumably associated with the low density membrane domain that contains decreased levels of blycerophospholipids and sphingomyelin. J Biol Chem. 2000 Sep 8;275(36):27901-8.

  

Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry. 2000 Sep 5;39(35):10831-9.

  

Yoo AS, Cheng I, Chung S, Grenfell TZ, Lee H, Pack-Chung E, Handler M, Shen J, Xia W, Tesco G, Saunders AJ, Ding K, Frosch MP, Tanzi RE, Kim TW. Presenilin-mediated modulation of capacitative calcium entry. Neuron. 2000 Sep;27(3):561-72.

Hoppe T, Matuschewski K, Rape M, Schlenker S, Ulrich HD, Jentsch S. Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing. Cell. 2000 Sep 1;102(5):577-86.

Takeda A, Smith MA, Avilá J, Nunomura A, Siedlak SL, Zhu X, Perry G, Sayre LM. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem. 2000 Sep;75(3):1234-41.

Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, Bush AI. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem. 2000 Sep 1;75(3):1219-33.

Wang HY, Lee DH, Davis CB, Shank RP. Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem. 2000 Sep;75(3):1155-61.

 

Miravalle L, Tokuda T, Chiarle R, Giaccone G, Bugiani O, Tagliavini F, Frangione B, Ghiso J. Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem. 2000 Sep 1;275(35):27110-6.

Weaver CL, Espinoza M, Kress Y, Davies P. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging. 2000 Sep-Oct;21(5):719-27.

 

Solomon B, Frenkel D. Vaccination for the prevention and treatment of alzheimer's disease. Drugs Today (Barc). 2000 Sep;36(9):655-63.

Roman G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc). 2000 Sep;36(9):641-53.

Rodriguez Martin T, Calella AM, Silva S, Munna E, Modena P, Chiesa R, Terrevazzi S, Ruggieri RM, Palermo R, Piccoli F, Confalonieri R, Tiraboschi P, Fragiacomo C, Quadri P, Lucca U, Forloni G. Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord. 2000 Sep-Oct;11(5):239-44. ,

Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry. 2000 Sep 1;157(9):1399-405.

Ott BR, Heindel WC, Tan Z, Noto RB. Lateralized cortical perfusion in women with Alzheimer's disease. J Gend Specif Med. 2000 Sep-Oct;3(6):29-35.

Smith MA, Nunomura A, Zhu X, Takeda A, Perry G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal. 2000 Fall;2(3):413-20.

 

Gurwitz D. New imaging techniques for early diagnosis of Alzheimer's disease. Mol Med Today. 2000 Sep;6(9):340.

Alvarez XA, Pichel V, Pérez P, Laredo M, Corzo D, Zas R, Fernández-Novoa L, Sempere JM, Díaz J, Cacabelos R. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics. Methods Find Exp Clin Pharmacol. 2000 Sep;22(7):585-94.

Li F, Iseki E, Kato M, Adachi Y, Akagi M, Kosaka K. An autopsy case of Alzheimer's disease presenting with primary progressive aphasia: a clinicopathological and immunohistochemical study. Neuropathology. 2000 Sep;20(3):239-45.

Maelicke A. Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease. Dement Geriatr Cogn Disord. 2000 Sep 1;11 Suppl 1:11-8.

Cadavid D, Mena H, Koeller K, Frommelt RA. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol. 2000 Sep;59(9):768-73.

Orgogozo JM. New millennium: new expectations for Alzheimer's disease? Dement Geriatr Cogn Disord. 2000 Sep;11 Suppl 1:1-2.

Johnson N, Davis T, Bosanquet N. The epidemic of Alzheimer's disease. How can we manage the costs? Pharmacoeconomics. 2000 Sep;18(3):215-23.

Tuszynski MH. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons. Cell Transplant. 2000 Sep-Oct;9(5):629-36.

Howland SC. Managing the Alzheimer's patient. Emerg Med Serv. 2000 Sep;29(9):89-92.

Urasaki K, Kuriki K, Namerikawa M, Satoh S, Ikeguchi K, Fukayama M, Saito K, Nakano I. An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap. Neuropathology. 2000 Sep;20(3):233-8.

Seno H, Inagaki T, Yamamori C, Miyaoka T, Horiguchi J. Dementia of Alzheimer type with and without multiple lacunar infarctions: evaluation of white matter lesions. Neuropathology. 2000 Sep;20(3):204-9.

Durany N, Ravid R, Riederer P, Cruz-Sánchez FF. Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathy. Neuropathology. 2000 Sep;20(3):184-9. ,

 

Ihara Y. [The current status and perspectives in Alzheimer's disease research] Nippon Ronen Igakkai Zasshi. 2000 Sep;37(9):680-6.

Karlsson E, Jolkkonen M, Mulugeta E, Onali P, Adem A. Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors. Biochimie. 2000 Sep-Oct;82(9-10):793-806.

Armon C, Peterson GW, Liwnicz BH. Alzheimer's disease underlies some cases of complex partial status epilepticus. J Clin Neurophysiol. 2000 Sep;17(5):511-8.

Terao T. Visual hallucinations in Alzheimer's disease: possible involvement of low visual acuity and dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci. 2000 Fall;12(4):516-8.

Tractenberg RE, Patterson M, Weiner MF, Teri L, Grundman M, Thomas RG, Thal LJ. Prevalence of symptoms on the CERAD behavior rating scale for dementia in normal elderly subjects and Alzheimer's disease patients. J Neuropsychiatry Clin Neurosci. 2000 Fall;12(4):472-9.

Corder EH, Woodbury MA, Volkmann I, Madsen DK, Bogdanovic N, Winblad B. Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging. Exp Gerontol. 2000 Sep;35(6-7):851-64.

Kienlen-Campard P, Tasiaux B, Octave JN. The processing and biological function of the human amyloid precursor protein (APP): lessons from different cellular models. Exp Gerontol. 2000 Sep;35(6-7):843-50.

Dewachter I, Van Dorpe J, Spittaels K, Tesseur I, Van den Haute C, Moechars D, Van Leuven F. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice. Exp Gerontol. 2000 Sep;35(6-7):831-41.

Stolz M, Stoffler D, Aebi U, Goldsbury C. Monitoring biomolecular interactions by time-lapse atomic force microscopy. J Struct Biol. 2000 Sep;131(3):171-80.

Harwood DG, Barker WW, Ownby RL, Duara R. Clinical characteristics of community-dwelling black Alzheimer's disease patients. J Natl Med Assoc. 2000 Sep;92(9):424-9.

Deng Z, Coudray C, Gouzoux L, Mazur A, Rayssiguier Y, Pépin D. Effects of acute and chronic coingestion of AlCl3 with citrate or polyphenolic acids on tissue retention and distribution of aluminum in rats. Biol Trace Elem Res. 2000 Sep;76(3):245-56.

Sawyer N. The state of affairs in Alzheimer disease. Case Manager. 2000 Sep-Oct;11(5):61-8.

Kim HT, Russell RL, Raina AK, Harris PL, Siedlak SL, Zhu X, Petersen RB, Shimohama S, Smith MA, Perry G. Protein disulfide isomerase in Alzheimer disease. Antioxid Redox Signal. 2000 Fall;2(3):485-9.

Naranjo CA, Fourie J, Herrmann N, Lanctôt KL, Birt C, Yau KK. Probing peripheral and central cholinergic system responses. J Psychiatry Neurosci. 2000 Sep;25(4):325-36.

Couderc R. [Search of biological markers of Alzheimer's disease] Ann Biol Clin (Paris). 2000 Sep-Oct;58(5):581-93.

Hirakura Y, Yiu WW, Yamamoto A, Kagan BL. Amyloid peptide channels: blockade by zinc and inhibition by Congo red (amyloid channel block). Amyloid. 2000 Sep 1;7(3):194-9.

Giunta S, Ronchi P, Valli B, Franceschi C, Galeazzi L. Transformation of beta-amyloid (A beta) (1-42) tyrosine to L-dopa as the result of in vitro hydroxyl radical attack. Amyloid. 2000 Sep;7(3):189-93.

Inouye H, Nguyen JT, Fraser PE, Shinchuk LM, Packard AB, Kirschner DA. Histidine residues underlie Congo red binding to A beta analogs. Amyloid. 2000 Sep;7(3):179-88.

Davies TA, Long HJ, Eisenhauer PB, Hastey R, Cribbs DH, Fine RE, Simons ER. Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system. Amyloid. 2000 Sep;7(3):153-65.

Siegel GJ, Chauhan NB. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev. 2000 Sep;33(2-3):199-227.

Parvizi J, Van Hoesen GW, Damasio A. Selective pathological changes of the periaqueductal gray matter in Alzheimer's disease. Ann Neurol. 2000 Sep;48(3):344-53.

Styren SD, Hamilton RL, Styren GC, Klunk WE. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J Histochem Cytochem. 2000 Sep;48(9):1223-32.

Hussain AM, Mitra AK. Effect of aging on tryptophan hydroxylase in rat brain: implications on serotonin level. Drug Metab Dispos. 2000 Sep;28(9):1038-42.

Marques AR, Weir SC, Fahle GA, Fischer SH. Lack of evidence of Borrelia involvement in Alzheimer's disease. J Infect Dis. 2000 Sep;182(3):1006-7.

Licastro F, Pedrini S, Ferri C, Casadei V, Govoni M, Pession A, Sciacca FL, Veglia F, Annoni G, Bonafè M, Olivieri F, Franceschi C, Grimaldi LM. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol. 2000 Sep;48(3):388-91. , ,

Meng G, Yuan J, An L, Gong J, Zhu H, Cui S, Yu Z, Hu G. An association study of polymorphisms in the alpha-antichymotrypsin gene for Alzheimer disease in Han-Chinese. Hum Mutat. 2000 Sep;16(3):275-6. ,

Narain Y, Yip A, Murphy T, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Furlong RA, Rubinsztein DC. The ACE gene and Alzheimer's disease susceptibility. J Med Genet. 2000 Sep;37(9):695-7. ,

Zurutuza L, Verpillat P, Raux G, Hannequin D, Puel M, Belliard S, Michon A, Pothin Y, Camuzat A, Penet C, Martin C, Brice A, Campion D, Clerget-Darpoux F, Frebourg T. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Eur J Hum Genet. 2000 Sep;8(9):713-6. , ,

Lippa CF, Swearer JM, Kane KJ, Nochlin D, Bird TD, Ghetti B, Nee LE, St George-Hyslop P, Pollen DA, Drachman DA. Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann Neurol. 2000 Sep 1;48(3):376-9. ,